Literature DB >> 9270046

Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.

W Pan1, W A Banks, A J Kastin.   

Abstract

Spinal cord injury (SCI) in mammals has a poor outcome because of a lack of regeneration. Alteration of the local environment after injury may induce regeneration. However, the passage of blood-borne or exogenous neurotrophic substances through the blood-brain barrier (BBB) is not well characterized in either normal or injured states. We investigated the permeability of the BBB in normal and injured states to two markers of permeability (albumin and sucrose), to a peptide (ebiratide), and to a cytokine [tumor necrosis factor-alpha(TNF)]. We found that in normal mice the cervical and lumbar areas of the spinal cord were more permeable than the thoracic area and the brain to all four substances. The penetration of the alpha-MSH/ACTH analogue ebiratide and of TNF, substances that have saturable transport systems across the BBB and may be involved in regenerative processes in the CNS, followed a regional pattern of differential permeability comparable to that of albumin and sucrose. Complete transection at the lumbar level induced a temporal change in the permeability of the BBB. The increased permeability, as measured by the radioactively labeled tracers albumin and sucrose, was most apparent in the lumbar region proximal to the transection. After SCI, the permeability to ebiratide remained unchanged, suggesting that disruption of the BBB did not affect the transport system for ebiratide. By contrast, the increase of permeability to TNF exceeded that detected by the markers albumin and sucrose. This enhanced permeability was inhibited by excess unlabeled TNF in the blood, showing saturability. This suggests that the transport system for TNF may be activated in SCI.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270046     DOI: 10.1006/exnr.1997.6533

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  28 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 2.  Adipokines and the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Peptides       Date:  2007-05-06       Impact factor: 3.750

3.  Sleep restriction impairs blood-brain barrier function.

Authors:  Junyun He; Hung Hsuchou; Yi He; Abba J Kastin; Yuping Wang; Weihong Pan
Journal:  J Neurosci       Date:  2014-10-29       Impact factor: 6.167

4.  Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury.

Authors:  W Pan; A J Kastin; R L Bell; R D Olson
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

5.  Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier.

Authors:  Weihong Pan; Balazs Csernus; Abba J Kastin
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

6.  Permeation of blood-borne IL15 across the blood-brain barrier and the effect of LPS.

Authors:  Weihong Pan; Hung Hsuchou; Chuanhui Yu; Abba J Kastin
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

Review 7.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

Review 8.  Cytokine transport across the injured blood-spinal cord barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  Increased leptin permeation across the blood-brain barrier after chronic alcohol ingestion.

Authors:  Weihong Pan; Misty Barron; Hung Hsuchou; Hong Tu; Abba J Kastin
Journal:  Neuropsychopharmacology       Date:  2007-05-09       Impact factor: 7.853

10.  Cerebral microvascular IL15 is a novel mediator of TNF action.

Authors:  Weihong Pan; Chuanhui Yu; Hung Hsuchou; Reas S Khan; Abba J Kastin
Journal:  J Neurochem       Date:  2009-08-31       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.